646
Participants
Start Date
April 30, 2007
Primary Completion Date
March 31, 2008
Study Completion Date
March 31, 2008
laropiprant/niacin (MK0524A)
"Treatment Period 1: one 20mg/1g tablet laropiprant/niacin once daily for 4 weeks~Treatment Period 2: two 20mg/1g tablets laropiprant/niacin once daily for 8 weeks.~All patients will receive placebo for a 4 week run-in period before randomization"
Comparator: placebo
"Treatment Period 1: one 20mg/1g tablet placebo to laropiprant/niacin once daily for 4 weeks~Treatment Period 2: two 20mg/1g tablets of placebo to laropiprant/niacin once daily for 8 weeks.~All patients will receive placebo for a 4 week run-in period before randomization."
Merck Sharp & Dohme LLC
INDUSTRY